Skip to content
CICigna

What Is CI Fair Value?

Cigna (CI) fair value estimate using multiple valuation models, updated daily.

As of October 14, 2026, Cigna (CI) has a composite fair value estimate of $647.48 based on four valuation models: DCF (35% weight), Graham Number (25% weight), PEG (25% weight), and DDM (15% weight). The current market price is $282.53, suggesting the stock is undervalued by 129.2%.

Data as of October 14, 2026 (today)

Composite Fair Value

Undervalued4 of 4 models

$647.48

vs. current price of $282.53(+129.2%)

Undervalued$647.48Overvalued
$282.53

How Is CI Fair Value Calculated?

Four independent models estimate what CI is worth. Each uses different inputs and assumptions. The composite blends them by weight.

CI Intrinsic Value

Forward-looking models based on future cash flows

DCF (Discounted Cash Flow)

35% weight

Estimates how much cash the company will generate over the next 10 years, then calculates what all that future cash is worth in today's dollars. Includes a 15% safety cushion. Try the standalone DCF calculator →

$1,110.38

+293.0%

Undervalued

Inputs used

FCF: 8BGrowth: 6.0%Discount: 5%

DDM (Dividend Discount Model)

15% weight

If a company pays you dividends, this model asks: how much are all those future dividend payments worth today? Only works for stocks that pay dividends. Try the intrinsic value calculator →

$204.75

-27.5%

Overvalued

Inputs used

Dividend: $6.24/yrReq. Return: 6%Growth: 3.0%

CI Fair Value

Current fundamentals: earnings, assets, and growth rate

Graham Number (Value Investing)

25% weight

Created by legendary investor Benjamin Graham. It looks at two things: how much the company earns (EPS) and what its assets are worth (Book Value), then calculates the maximum price a careful investor should pay. Try the fair value calculator →

$333.09

+17.9%

Undervalued

Inputs used

EPS: $30.51Book Value: $161.62

PEG (Price/Earnings to Growth)

25% weight

Checks if you're paying a fair price for the company's growth. A fast-growing company deserves a higher price than a slow one. This model finds the right price based on how fast earnings are growing.

$305.10

+8.0%

Fair Value

Inputs used

EPS: $30.51Growth: 6.0%

What If You Change the Assumptions?

Drag the sliders to test different scenarios. Tap the ? buttons to learn what each input means.

Your DCF Fair Value

$1110.38Undervalued

Current price $282.53 is 293.0% below this estimate

CheapFair ValueExpensive
6.0%
0.0%30.0%
5.5%
6.0%15.0%
2.5%
1.0%4.0%
15.0%
0.0%50.0%
View 10-year cash flow projections
YearProjected FCF (Free Cash Flow)Present Value
Year 1$8.46B$8.02B
Year 2$8.97B$8.06B
Year 3$9.50B$8.10B
Year 4$10.07B$8.14B
Year 5$10.68B$8.18B
Year 6$11.32B$8.22B
Year 7$12.00B$8.26B
Year 8$12.72B$8.30B
Year 9$13.48B$8.34B
Year 10$14.29B$8.38B
Terminal Value$490.90B$287.83B

What Are CI's Key Financial Metrics?

Earnings & Growth

Current Price

$282.53

EPS (TTM)

$24.19

Forward P/E

8.4

Profit Margin

2.3%

Cash & Balance Sheet

Free Cash Flow

8B

EBITDA

12.8B

Book Value

$161.62

Total Debt

31.9B

What Do Analysts Say About CI?

Low

$288.00

Average

$342.29

High

$400.00

Upside

+21.2%

Current $282.53Avg Target $342.29Buy24 analysts

CI Fair Value FAQ

What is the fair value of CI?

Based on our composite model (DCF 35%, Graham 25%, PEG 25%, DDM 15%), CI's estimated fair value is $647.48. The stock is currently trading at $282.53, which makes it undervalued by our analysis.

How is CI's fair value calculated?

We use four valuation methods: Discounted Cash Flow (DCF), Graham Number, PEG-based Fair Value, and Dividend Discount Model (for dividend-paying stocks). The composite score weights DCF at 35%, Graham and PEG at 25% each, and DDM at 15%. When a model can't be applied, its weight is redistributed proportionally.

Is CI overvalued or undervalued?

Based on our analysis, CI is undervalued. The current price of $282.53 is 129.2% below our estimated fair value of $647.48.

What do Wall Street analysts say about CI?

24 analysts cover Cigna with a consensus rating of "Buy." The average price target is $342.29, ranging from $288.00 to $400.00. This implies 21.2% upside from the current price.